Due to suspected violations of laws and regulations in information disclosure, Tiansheng Pharmaceutical Group (002872.SZ) and its controlling shareholder Liu Qun are under investigation.

Tiansheng Pharmaceutical Group (002872.SZ) issued an announcement stating that the company, its controlling shareholder, and the actual controller, Mr. Liu Qun, received a "Notice of Case Filing" (No. 0152025001 and No. 0152025002) from the China Securities Regulatory Commission ("CSRC") on January 7, 2025, for suspected violations of laws and regulations related to information disclosure. In accordance with the laws and regulations such as the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China, the CSRC has decided to initiate a case against the company, its controlling shareholder, and the actual controller, Mr. Liu Qun. During the investigation period, the company, its controlling shareholder, and the actual controller, Mr. Liu Qun, will actively cooperate with the relevant work of the CSRC. Currently, the company's production and operation are normal.